National Research (NASDAQ:NRC) Share Price Passes Above Two Hundred Day Moving Average – What’s Next?

National Research Corporation (NASDAQ:NRC) crossed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $15.98 and traded as high as $17.59. National Research shares last traded at $17.34, with a volume of 60,208 shares trading hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings lowered shares of National Research from a “hold (c-)” rating to a “sell (d+)” rating in a report on Friday, March 6th. One research analyst has rated the stock with a Sell rating, According to MarketBeat, the company currently has a consensus rating of “Sell”.

National Research Price Performance

The company has a market capitalization of $394.42 million, a PE ratio of 34.68 and a beta of 0.53. The company has a current ratio of 0.55, a quick ratio of 0.55 and a debt-to-equity ratio of 5.36. The company’s 50 day moving average price is $16.04 and its 200-day moving average price is $15.98.

National Research (NASDAQ:NRC) last issued its earnings results on Tuesday, February 3rd. The company reported $0.16 earnings per share for the quarter. National Research had a return on equity of 103.84% and a net margin of 8.44%.The business had revenue of $35.19 million for the quarter.

National Research Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, April 10th. Stockholders of record on Friday, March 27th will be issued a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a dividend yield of 3.7%. The ex-dividend date is Friday, March 27th. National Research’s dividend payout ratio (DPR) is 128.00%.

Institutional Trading of National Research

A number of institutional investors have recently modified their holdings of the company. CANADA LIFE ASSURANCE Co purchased a new position in National Research in the fourth quarter valued at approximately $60,000. Raymond James Financial Inc. acquired a new position in National Research during the second quarter valued at approximately $34,000. Strs Ohio purchased a new stake in National Research during the first quarter worth approximately $33,000. EverSource Wealth Advisors LLC grew its stake in National Research by 9,535.3% during the second quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock worth $28,000 after buying an additional 1,621 shares during the period. Finally, Russell Investments Group Ltd. increased its position in shares of National Research by 85.6% in the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after acquiring an additional 921 shares in the last quarter. Hedge funds and other institutional investors own 47.26% of the company’s stock.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.